Description

Phenibut HCL + FLModafinil (CRL-40,940) – Product Information

Phenibut HCL and FLModafinil consist of:

• 250mg per capsule Phenibut HCL
• 50mg per capsule FLModafinil (CRL-40,940)

This is offered in 2 variants:

• 300mg per capsule for 30capsules, totaling 16.5g.
• 300mg per capsule for 60 capsules, totaling 33g.

Phenibut HCL and FLModafinil (CRL-40,940) can be studied synergistically for their potential cognitive and mood-enhancing effects. Phenibut HCL, a derivative of the neurotransmitter gamma-aminobutyric acid (GABA), is known for its anxiolytic and nootropic properties, potentially improving mood and reducing stress.

FLModafinil, a modafinil analog, may potentially enhance wakefulness and cognitive function. When studied together, these compounds may offer a unique combination of mood stabilization, cognitive enhancement, and alertness.

Phenibut HCL

Phenibut HCL is a synthetic neuropsychotropic compound initially developed in Russia. It is currently studied for its potential to treat anxiety, alcohol withdrawal, insomnia, tension, and stammering.

Preclinical studies have reported that Phenibut HCL possesses anti-convulsant properties. The compound has also exhibited nootropic (cognition enhancing) and anxiolytic effects in various mice studies.

FLModafinil (CRL-40,940)

Modafinil, also known as CRL-40,940 (Flmodafinil, Lauflumide), has the potential to improve focus and lessen the desire to sleep and is being researched for its potential to treat narcoleptics. In animal models, CRL-40,940, a psychotonic and eugeroic substance, produced effects that were comparable to but slightly stronger than those of modafinil.